Odactra
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.odactra.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Odactra
ALK-Abell, Inc. specializes in developing ODACTRA®, a prescription medicine designed for sublingual immunotherapy to treat house dust mite allergies in individuals aged 5 to 65. The product helps alleviate symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes caused by house dust mites. ODACTRA is intended for patients who have not found relief with other allergy medications and aims to provide a long-term solution, though it does not offer immediate symptom relief. The company emphasizes safety and provides thorough information for both patients and healthcare professionals regarding the administration and potential reactions associated with ODACTRA.Explore more
Popular SearchesOdactraSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Odactra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Odactra
Click to see if Odactra had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Odactra has new funding data
Earning: See what the market has to say on Odactra recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Odactra, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Odactra launches new products
Website visits: Recent activity has been detected on your website
Check if Odactra has recently received funding, and reach out quickly before it becomes old news!
Check out if Odactra is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Odactra
Compare insights from companies similar to Odactra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Odactra is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Odactra is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Odactra.
Odactra Tech Stack
A closer look at the technologies used by Odactra
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Odactra
Sign Up For FreeTo access detailed company insights
ALK-Abell, Inc. specializes in developing ODACTRA®, a prescription medicine designed for sublingual immunotherapy to treat house dust mite allergies in individuals aged 5 to 65. The product helps alleviate symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes caused by house dust mites. ODACTRA is intended for patients who have n... Read More
